However, in the analysis of several breast cancer datasets, previous reports showed differences of subtype-specific mRNA and promoter methylation in IDO1, with TNBC/basal subtypes exhibiting low methylation/higher expression phenotype and ER+/luminal subtypes demonstrating high methylation/lower expression phenotype (15). The gene discussed is ESR1; the disease is breast cancer.